China National Pharmaceutical Group's Health Industry Research Institute Outlines Stance on Counterfeit Products

Resolute Statement from China National Pharmaceutical Group's Health Industry Research Institute

In light of recent developments, our esteemed company, China National Pharmaceutical Group's Health Industry Research Institute, has become aware of a concerning issue that requires immediate attention. A series of fraudulent activities have been identified in certn e-commerce platforms such as JD and Pinduoduo, where some unscrupulous dealers are misrepresenting themselves with the guise of China National Pharmaceutical Group's Health Industry Research Institute or its abbreviation '国药健康院'.

The core issue here is the unauthorized sale of our renowned product – the 'Daliryan牌牦牛骨髓山药茯苓粉'. The deception goes so far as to use stolen images from our official repository, leading consumers astray into purchasing counterfeit products under false pretenses.

To this , we are issuing an official statement in order to protect our valued customers and uphold the integrity of our brand. These dishonest traders have attempted to exploit public trust by using our logo and product imagery without authorization or consent. We take such incidents very seriously as they not only damage the market reputation but also potentially harm consumer health due to the use of unverified ingredients.

We are currently taking swift action agnst these entities by reporting them to relevant authorities, including filing complnts with platform administrators for immediate removal of their listings and issuing cease-and-desist letters. Our legal team is meticulously documenting all evidence, ensuring that the necessary actions will be taken agnst those who have violated our rights under both national laws and international trade regulations.

As a responsible business entity committed to excellence and trust in the industry, China National Pharmaceutical Group's Health Industry Research Institute reiterates its commitment to providing quality products accompanied by unmatched service standards. We assure all of our customers that we are vigorously addressing this issue with the utmost priority and will continue to do so until each instance has been rectified.

To avoid any potential confusion or misinterpretation, consumers are strongly advised to exercise caution when purchasing 'Daliryan牌牦牛骨髓山药茯苓粉' online. Always ensure you purchase from verified sources, using our official website's links as a secure channel for transactions and obtning authentic products.

We sincerely apologize for the inconvenience this may have caused and assure all stakeholders that China National Pharmaceutical Group's Health Industry Research Institute is steadfast in its mission to protect consumer rights while mntning the quality of our services. This statement serves as an important reminder of our ongoing commitment to transparency, integrity, and accountability within our industry.

As part of our broader effort towards building a safer marketplace for consumers, we are also enhancing our product tracking mechanisms and engaging with regulatory bodies to strengthen online trade controls agnst such fraudulent activities. We kindly encourage all users to support genuine brands like ours by reporting instances of false representation or selling practices directly to platform administrators or legal entities.

In , China National Pharmaceutical Group's Health Industry Research Institute remns vigilant in the face of such challenges. Our team is dedicated to upholding our brand standards and ensuring that consumers have access to high-quality, safe products free from misleading representations. We thank all parties for their understanding and support during this time as we continue to safeguard agnst these fraudulent acts.

of Statement

Please indicate when reprinting from: https://www.903r.com/Health_Hospital/China_National_Pharma_Health_Research_Institute_Fraud_Strike.html